Martin Shkreli ordered to return $64M; permanently barred from drug industry
Published
Published
The former executive who shot to notoriety for hiking the price of a lifesaving medication has been ordered to pay $US65 million..
A federal judge found that Mr. Shkreli violated state and federal antitrust laws by trying to maintain a monopoly over a lifesaving..